Insider Transactions in Q1 2022 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2022
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
1,787
-1.69%
|
$19,657
$11.38 P/Share
|
|
Mar 03
2022
|
Thomas Charles Reilly Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,044
-5.13%
|
$22,484
$11.38 P/Share
|
|
Feb 28
2022
|
Thomas Charles Reilly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,333
+11.8%
|
$53,330
$10.29 P/Share
|
|
Feb 28
2022
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
5,333
+4.8%
|
-
|
|
Feb 25
2022
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,972
-2.51%
|
$19,720
$10.29 P/Share
|
|
Feb 25
2022
|
Joana Goncalves CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+20.3%
|
-
|
|
Feb 25
2022
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
2,114
-1.22%
|
$21,140
$10.29 P/Share
|
|
Feb 25
2022
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+10.33%
|
-
|
|
Feb 25
2022
|
Christopher Posner PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+16.11%
|
-
|
|
Feb 25
2022
|
Thomas Charles Reilly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.68%
|
-
|
|
Feb 25
2022
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
1,972
-1.93%
|
$19,720
$10.29 P/Share
|
|
Feb 25
2022
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+16.34%
|
-
|